"El Instituto de Corazón de Querétaro fue fundado por cinco innovadores médicos cardiólogos, quienes conscientes de la problemática de salud en México así como en nuestro Estado de Querétaro, se comprometieron en el año 2004 para crear esta empresa privada, quienes invitaron a personal del ámbito cardiológico y áreas afines (Nefrología, Neurología, Medicina Interna, Neumología, Infectología, Cirugía, Angiología, Áreas críticas, Nutrición)."

During the past decade, Instituto de Corazón de Querétaro conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 3 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 2 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Instituto de Corazón de Querétaro" are "Pulmonary Arterial Hypertension" (2 trials), "Atrial Fibrillation" (1 trials) and "Stroke" (1 trials). Many other conditions were trialed in "Instituto de Corazón de Querétaro" in a lesser frequency.

Most popular intervention types in "Instituto de Corazón de Querétaro" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Macitentan 10 mg" (1 trials), "Macitentan 10 mg tablet, once daily." (1 trials) and "Placebo" (1 trials). Other intervention names were less common.

The vast majority of trials in "Instituto de Corazón de Querétaro" are 3 trials for "All" genders.

Currently, there are NaN active trials in "Instituto de Corazón de Querétaro". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Instituto de Corazón de Querétaro, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Instituto de Corazón de Querétaro, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".